KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Assets Growth (1y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.22%
Dec 31, 2025 -0.89%
Sep 30, 2025 -6.64%
Jun 30, 2025 -3.35%
Mar 31, 2025 -8.54%
Dec 31, 2024 0.33%
Sep 30, 2024 5.29%
Jun 30, 2024 4.85%
Mar 31, 2024 10.65%
Dec 31, 2023 -2.95%
Sep 30, 2023 -3.61%
Jun 30, 2023 -5.46%
Mar 31, 2023 -6.05%
Dec 31, 2022 -5.27%
Sep 30, 2022 -5.06%
Jun 30, 2022 -3.23%
Mar 31, 2022 -4.84%
Dec 31, 2021 -2.68%
Sep 30, 2021 -0.51%
Jun 30, 2021 -1.04%
Mar 31, 2021 65.02%
Dec 31, 2020 68.96%
Sep 30, 2020 151.71%
Jun 30, 2020 161.68%
Mar 31, 2020 60.65%
Dec 31, 2019 50.15%
Sep 30, 2019 -10.16%
Jun 30, 2019 -7.30%
Mar 31, 2019 -18.13%
Dec 31, 2018 -16.15%
Sep 30, 2018 -3.89%
Jun 30, 2018 -7.99%
Mar 31, 2018 5.60%
Dec 31, 2017 7.09%
Sep 30, 2017 3.32%
Jun 30, 2017 -0.32%
Mar 31, 2017 22.23%
Dec 31, 2016 24.60%
Sep 30, 2016 21.51%
Jun 30, 2016 24.80%
Mar 31, 2016 101.21%
Dec 31, 2015 92.82%
Sep 30, 2015 92.70%
Jun 30, 2015 85.42%
Mar 31, 2015 -6.83%
Dec 31, 2014 -5.77%
Sep 30, 2014 0.71%
Jun 30, 2014 4.07%
Mar 31, 2014 5.48%
Dec 31, 2013 8.11%